Meet Linnae Ponte, LMFT:
Linnae Ponte, LMFT, is an integral psychotherapist who specializes in working with adult individuals and couples. Her training is grounded in transpersonal psychotherapy, which is informed by depth psychology, existential/humanistic perspectives, and perennial philosophy. Her approach is person-centered, and recognizes that clients benefit most from the truth that they, themselves, discover.
About Linnae Ponte
Linnae has worked as a clinical facilitator on psychedelic clinical trials researching psilocybin for PTSD, MDD and OCD at the Yale School of Medicine and UCSF's Translational Psychedelic Research Program (TrPR) and was an adherence rater for the MDMA-Assisted Therapy trials conducted by MPBC. She holds a Master’s degree in Counseling Psychology from CIIS and a Bachelor’s degree in Biological Psychology from New College of Florida.
Background & Education
- Licensed Marriage and Family Therapist with 10+ years of experience in psychedelic-assisted therapy, clinical research, and harm reduction.
- Clinical facilitator for psilocybin therapy trials at UCSF and Yale University.
- Adherence rater for MDMA-assisted psychotherapy studies with Lykos Therapeutics (formerly MAPS).
- Founding Director and current Board Member of the Zendo Project, training hundreds in psychedelic harm reduction.
- Holds an M.A. in Counseling Psychology (California Institute of Integral Studies) and a B.A. in Biological Psychology(New College of Florida).
- Advanced training in MDMA and psilocybin-assisted therapy, Internal Family Systems (IFS), and trauma-informed care.
Linnae's Areas of Specialization
- Conditions Treated: Depression, PTSD/trauma, anxiety, OCD, substance and alcohol use, and end-of-life or existential distress.
- Approach: Psychedelic-assisted therapy (psilocybin, MDMA), harm reduction, integration therapy, Internal Family Systems (IFS), and client-centered psychotherapy.
- Clinical Trials: Facilitator for psilocybin studies at UCSF and Yale; adherence rater for MDMA-assisted therapy with Lykos Therapeutics.
- Research Contributions: Co-author of peer-reviewed studies on psychedelic therapies and contributor to MDMA therapy manuals and protocols.
- Leadership: Founding Director and current Board Member of the Zendo Project, advancing psychedelic harm reduction worldwide.
Research & Publications
Peer-Reviewed Articles:
- Sleep changes in MDMA-assisted psychotherapy treatment subjects with chronic, treatment-resistant PTSD.Journal of Traumatic Stress, 2021.
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology, 2020.
- History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS). Journal of Psychoactive Drugs, 2014.
You don’t have to be sure. Just open to learning more.
Our team is here to answer your questions